Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Clinical Spectrum of Hypersensitivity and Granulomatous Reactions to VenaSeal™ Cyanoacrylate Closure.

Clinical Spectrum of Hypersensitivity and Granulomatous Reactions to VenaSeal™ Cyanoacrylate Closure. Dermatitis : contact, atopic, occupational, drug Shah, M. M., Fukaya, E., Honari, G., Chen, J. K., Bae, G. H. 2026: 17103568261446233

Abstract

The VenaSeal™ Closure System uses n-butyl-2-cyanoacrylate for minimally invasive treatment of chronic venous disease. While generally safe, reported adverse events include phlebitis, hypersensitivity, foreign body granulomas, and endovenous glue-induced thrombosis. Specifically, hypersensitivity reactions have been reported in 6.3%-13% of patients.We present 4 patients with heterogeneous cutaneous and systemic reactions following CAC, ranging from localized nodules to erythroderma. Diagnostic evaluation included patch testing, ultrasound, CT, and histopathology, with varying findings for each case.Consequently, treatments ranged from intralesional corticosteroids to prolonged systemic corticosteroids and surgical excision.This case series highlights the limitations of patch testing, the importance of considering imaging and biopsy for diagnosis, and the need for individualized management strategies.

View details for DOI 10.1177/17103568261446233

View details for PubMedID 42077140